National Institutes of Health: Mastocytosis trials
The registry lists 11 Mastocytosis studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 2 have results posted.
Phase 2 4No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of Factors Regulating Mast Cell ProliferationRecruitingNCT00044122
- COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 VaccinationsCompletedNCT04761822Phase 2Results posted
- Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic MastocytosisCompletedNCT03770273Phase 2Results posted
- Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory DisordersTerminatedNCT00557895
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic MastocytosisCompletedNCT00132015Phase 2
- Cause and Natural Course of Pediatric-Onset MastocytosisCompletedNCT00050193
- Blood Factors in Mastocytosis and Unexplained Anaphylaxis and FlushingCompletedNCT00047918
- Stem Cell Transplantation to Treat Systemic MastocytosisCompletedNCT00006413Phase 2
- Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy IndividualsCompletedNCT00001760
- Study of Mast Cell PrecursorsCompletedNCT00001756
- Characteristics of Mast Cells in MastocytosisCompletedNCT00001356